Cochlear Ltd (ASX: COH) and ResMed Inc. (ASX: RMD) shares could be strong buys. Let's see what one leading broker is ...

Researchers map the peptide behind semaglutide across 25 brain regions in each sex, finding striking differences in ...

Many of the major healthcare stocks on the ASX are looking cheap, Wilsons Advisory says, with some offering great value at ...

Researchers have found hundreds of metabolic enzymes attached to human DNA inside the cell nucleus. Different tissues and cancers show unique patterns of these enzymes, forming a “nuclear metabolic ...

The drugs have names that sound like small planets: semaglutide, liraglutide, lixisenatide. Collectively, they belong to a ...

Hearing is one of those things most people never think about until it’s gone. For millions living with severe to profound hearing loss, a cochlear implant isn’t just a device. It’s a way back to ...

Cochlear, the global leader in implantable hearing solutions, today launched the Cochlear™ Nucleus® Nexa® System - the world's first and only smart cochlear implant system. The new Cochlear™ Nucleus® ...

Bone conduction hearing aids or hearing systems, also called osseointegrated or bone-anchored devices, are an innovative technology approved by the Food and Drug Administration to treat certain types ...

Six months after becoming the first patient in the United States to receive a newly FDA-approved cochlear implant system, 18-month-old Nene Gudavadze is responding to sound, dancing to music, and ...